Genotyping of the hepatitis C virus (HCV) RNA can be performed by a va
riety of methods following polymerase chain reaction amplification of
a stable RNA portion of the genome. The gold standard is amplification
of the RNA from the NS5 region, followed by direct sequencing and hom
ology comparison. This method is extremely labor intensive. In this st
udy, we compared an immunoblot serotyping technique (HCV STA) to a rev
erse-hybridization line-probe assay (LiPA) for genotype classification
among non-alcoholic HCV infected patients. We then compared and contr
asted the response in this cohort to a population of alcoholic patient
s with HCV infection. To validate the serotype assay, sera from 110 pa
tients with chronic HCV infection was utilized. Serotyping (Chiron SIA
) and genotyping by the LiPA (Line Probe Assay, Innogenetics) reverse-
hybridization technique was performed. Additionally, both methods were
compared to sequence-derived genotyping in 26 patients based on PCR a
mplification of the NS5 region. After the validation phase, sera from
105 alcoholic patients was genotypically classified by the serologic m
ethod. The nonalcoholic and alcoholic groups were then compared with r
egard to serotype, demographics, and frequency of untypable test resul
ts. Among typable pairs, the overall concordance rate between serotypi
ng and LiPA-based genotyping was 93.75%. Patients with genotype 1 by r
everse hybridization demonstrated a 95.8% concordance with serotype. U
ntypable samples were present for both techniques, but since they occu
rred in different patients, the techniques were complementary Alcoholi
c patients were significantly more likely to be infected with untypabl
e serotypes than those without a pattern of alcohol abuse. These patie
nts were also more likely to be HCV RNA negative than sera from typabl
e patients. Serotype 1 was associated with high HCV RNA titer and poor
interferon treatment response among both nonalcoholic and alcoholic p
atients. An immunoblot method for the evaluation of genotype classific
ation was rapid and easily performed compared to sequence-based genoty
ping. There was a high degree of concordance compared to reverse-hybri
dization and sequence-based genotype characterization methods, Failure
to detect HCV RNA in the serum is associated with a higher likelihood
of classification failure. This problem was particularly prevalent in
the alcoholic population HCV RNA titers and treatment outcomes were s
trongly associated with serotype classification results, demonstrating
clinical utility of this assay technique.